Therefore, it is speculated that a decrease in SLC20A1 expression could reduce the activation of the TNF/TNFR2 signaling pathway, thereby inhibiting Tregs, restoring tumor immune response, and eliminating the tumor. This evidence concerns the gene TNFRSF1B and neoplasm.